Abstract.
Pediatric renal transplant patients present a number of challenges and problems, especially the inhibited post-transplant growth seen in children receiving standard immunosuppressive triple therapy that includes steroids. We report the successful use of steroid-free immunosuppression since 1990 in 14 pediatric renal allograft recipients who received a 10-day initial course of antilymphocyte globulin and surface area-adjusted doses of cyclosporine, 7 of whom also received mycophenolate mofetil (MMF) as maintenance immunosuppression. Only 1 patient died (3 months after transplantation as a result of a primary Epstein-Barr virus infection-induced lymphoproliferative disorder), 1 patient’s graft never functioned, and another patient lost his graft after 3 years because of chronic rejection. Three patients experienced early acute cellular rejection, which resolved in 2 cases with OKT3, and in the 3rd with MMF. There were no late acute rejections. All patients evidenced growth and a growth spurt under this regimen. We conclude that all the pediatric patients benefited from our steroid-free protocol and that this protocol is superior to conventional triple therapies, which entail the eventual reduction and discontinuation of steroids, a procedure that not only inhibits growth but also carries an additional risk of acute rejection due to a steroid-adapted immune response.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received April 16, 1997; received in revised form September 8, 1997; accepted September 10, 1997
Rights and permissions
About this article
Cite this article
Birkeland, S., Larsen, KE. & Rohr, N. Pediatric renal transplantation without steroids. Pediatr Nephrol 12, 87–92 (1998). https://doi.org/10.1007/s004670050410
Issue Date:
DOI: https://doi.org/10.1007/s004670050410